node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ADK | ADO | ENSP00000286621 | ENSP00000362888 | adenosine kinase; ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides | 2-aminoethanethiol (cysteamine) dioxygenase | 0.648 |
ADK | ADORA1 | ENSP00000286621 | ENSP00000308549 | adenosine kinase; ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides | adenosine A1 receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase | 0.699 |
ADK | ADORA2B | ENSP00000286621 | ENSP00000304501 | adenosine kinase; ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides | adenosine A2b receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase | 0.414 |
ADK | RPIA | ENSP00000286621 | ENSP00000283646 | adenosine kinase; ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides | ribose 5-phosphate isomerase A | 0.463 |
ADK | TRIM33 | ENSP00000286621 | ENSP00000351250 | adenosine kinase; ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides | tripartite motif containing 33; Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway. According to PubMed-16751102, does not promote a decrease in the level of endogenous SMAD4. May act as a transcriptional repressor. Inhibits the transcriptional response to TGF-beta/BMP signaling cascade. Plays a role in the control of cell proliferation. Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/progenitor (By similarity). Monoubiquitinates SMAD4 and acts as a [...] | 0.720 |
ADO | ADK | ENSP00000362888 | ENSP00000286621 | 2-aminoethanethiol (cysteamine) dioxygenase | adenosine kinase; ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides | 0.648 |
ADO | ADORA1 | ENSP00000362888 | ENSP00000308549 | 2-aminoethanethiol (cysteamine) dioxygenase | adenosine A1 receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase | 0.525 |
ADO | ADORA2B | ENSP00000362888 | ENSP00000304501 | 2-aminoethanethiol (cysteamine) dioxygenase | adenosine A2b receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase | 0.581 |
ADO | C3 | ENSP00000362888 | ENSP00000245907 | 2-aminoethanethiol (cysteamine) dioxygenase | complement component 3; C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates | 0.610 |
ADO | CDON | ENSP00000362888 | ENSP00000263577 | 2-aminoethanethiol (cysteamine) dioxygenase | Cdon homolog (mouse); Component of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells. Promotes differentiation of myogenic cells (By similarity) | 0.785 |
ADO | CSAD | ENSP00000362888 | ENSP00000267085 | 2-aminoethanethiol (cysteamine) dioxygenase | cysteine sulfinic acid decarboxylase | 0.913 |
ADO | GAD1 | ENSP00000362888 | ENSP00000350928 | 2-aminoethanethiol (cysteamine) dioxygenase | glutamate decarboxylase 1 (brain, 67kDa); Catalyzes the production of GABA | 0.900 |
ADO | GAD2 | ENSP00000362888 | ENSP00000259271 | 2-aminoethanethiol (cysteamine) dioxygenase | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa); Catalyzes the production of GABA | 0.900 |
ADO | RPIA | ENSP00000362888 | ENSP00000283646 | 2-aminoethanethiol (cysteamine) dioxygenase | ribose 5-phosphate isomerase A | 0.655 |
ADO | TRIM33 | ENSP00000362888 | ENSP00000351250 | 2-aminoethanethiol (cysteamine) dioxygenase | tripartite motif containing 33; Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway. According to PubMed-16751102, does not promote a decrease in the level of endogenous SMAD4. May act as a transcriptional repressor. Inhibits the transcriptional response to TGF-beta/BMP signaling cascade. Plays a role in the control of cell proliferation. Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/progenitor (By similarity). Monoubiquitinates SMAD4 and acts as a [...] | 0.583 |
ADORA1 | ADK | ENSP00000308549 | ENSP00000286621 | adenosine A1 receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase | adenosine kinase; ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides | 0.699 |
ADORA1 | ADO | ENSP00000308549 | ENSP00000362888 | adenosine A1 receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase | 2-aminoethanethiol (cysteamine) dioxygenase | 0.525 |
ADORA1 | C3 | ENSP00000308549 | ENSP00000245907 | adenosine A1 receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase | complement component 3; C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates | 0.900 |
ADORA1 | RPIA | ENSP00000308549 | ENSP00000283646 | adenosine A1 receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase | ribose 5-phosphate isomerase A | 0.935 |
ADORA1 | TRIM33 | ENSP00000308549 | ENSP00000351250 | adenosine A1 receptor; Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase | tripartite motif containing 33; Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway. According to PubMed-16751102, does not promote a decrease in the level of endogenous SMAD4. May act as a transcriptional repressor. Inhibits the transcriptional response to TGF-beta/BMP signaling cascade. Plays a role in the control of cell proliferation. Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/progenitor (By similarity). Monoubiquitinates SMAD4 and acts as a [...] | 0.720 |